Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Allena Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −1 vs. Q1 2021
- Shares held
- 21.6M
- +1.26M (+6.2%) vs. Q1 2021
- Total value
- $28.1M
- −$193.0K (−0.7%) vs. Q1 2021
- New holders
- 3
- 10 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 2 | $4.00K |
| Q2 2022 | 25 | $1.71M |
| Q1 2022 | 28 | $1.86M |
| Q4 2021 | 30 | $10.1M |
| Q3 2021 | 36 | $18.0M |
| Q2 2021 | 29 | $28.1M |
| Q1 2021 | 30 | $28.3M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Allena Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 1,256 | $1.00K | 0.00% | +31+2.5% | Added |
| UBS Group AG | 2,500 | $3.00K | 0.00% | −7,274−74.4% | Reduced |
| Tower Research Capital LLC (TRC) | 3,935 | $5.00K | 0.00% | +3,813+3,125.4% | Added |
| Harbour Investments, Inc. | 5,500 | $7.00K | 0.00% | +2,500+83.3% | Added |
| Bank of America Corp | 5,918 | $8.00K | 0.00% | +18+0.3% | Added |
| Harbor Financial Services, LLC | 20,000 | $26.0K | 0.01% | 00.0% | Unchanged |
| Golden Green, Inc. | 21,000 | $27.0K | 0.02% | −8,000−27.6% | Reduced |
| Advisor Group Holdings, Inc. | 23,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 25,050 | $33.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 33,413 | $43.0K | 0.00% | −6,300−15.9% | Reduced |
| Bank of New York Mellon Corp | 34,026 | $44.0K | 0.00% | −5,160−13.2% | Reduced |
| State Street Corp | 34,258 | $45.0K | 0.00% | +34,258 | New |
| Citadel Advisors LLC | 47,630 | $62.0K | 0.00% | +47,630 | New |
| Northern Trust Corp | 65,299 | $85.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 73,000 | $95.0K | 0.00% | +73,000 | New |
| Millennium Management LLC | 187,431 | $244.0K | 0.00% | +80,625+75.5% | Added |
| BlackRock Inc. | 249,606 | $325.0K | 0.00% | +59,804+31.5% | Added |
| PFM Health Sciences, LP | 284,285 | $370.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 285,567 | $371.0K | 0.00% | +29,323+11.4% | Added |
| Bridgeway Capital Management, LLC | 351,000 | $456.0K | 0.01% | −30,200−7.9% | Reduced |
| Renaissance Technologies LLC | 700,601 | $911.0K | 0.00% | +214,671+44.2% | Added |
| Worth Venture Partners, LLC | 744,200 | $967.0K | 0.36% | −236,000−24.1% | Reduced |
| Morgan Stanley | 1,045,481 | $1.36M | 0.00% | +407,599+63.9% | Added |
| Vanguard Group Inc | 1,961,144 | $2.55M | 0.00% | +809,035+70.2% | Added |
| FMR LLC | 2,296,083 | $2.98M | 0.00% | 00.0% | Unchanged |
| TRV GP II, LLC | 2,790,964 | $3.63M | 10.71% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 3,000,000 | $3.90M | 0.02% | 00.0% | Unchanged |
| Frazier Management LLC | 3,330,373 | $4.33M | 0.40% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 4,000,000 | $5.20M | 1.41% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −137,900−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −40,200−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,382−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −9,019−100.0% | Sold out |